Fulltext

The landscape of antibiotic usage among COVID-19 patients in the early phase of pandemic: a Malaysian national perspective

Mohamad IN 1 , Wong CK 1 , Chew CC 2 , Leong EL 3 , Lee BH 1 , Moh CK 1 Show all authors , Chenasammy K 1 , Lim SC 4 , Ker HB 4

Affiliations 

  • 1 Medical Department, Hospital Raja Permaisuri Bainun, Ministry of Health, Ipoh, Malaysia
  • 2 Clinical Research Centre, Hospital Raja Permaisuri Bainun, Ministry of Health, Ipoh, Malaysia
  • 3 Clinical Research Centre, Hospital Raja Permaisuri Bainun, Ministry of Health, Ipoh, Malaysia. elileong.crc@gmail.com
  • 4 Infectious Diseases Unit, Medical Department, Hospital Raja Permaisuri Bainun, Ministry of Health, Ipoh, Malaysia
J Pharm Policy Pract, 2022 Jan 11;15(1):4.
PMID: 35016728 DOI: 10.1186/s40545-022-00404-4

Abstract

BACKGROUND: During the early phase of the COVID-19 pandemic, antibiotic usage among COVID-19 patients was noted to be high in many countries. The objective of this study was to determine the prevalence of antibiotic usage and factors affecting antibiotic usage among COVID-19 patients during the early phase of the COVID-19 pandemic in Malaysia.

METHODS: This was a cross-sectional study that involved reviewing medical records of COVID-19 Malaysian patients aged 12 and above who were diagnosed with COVID-19 and received treatment in 18 COVID-19 hospitals from February to April 2020. A minimum sample of 375 patients was required. A binary logistic regression analysis was performed to determine factors associated with antibiotic usage. Variables with p 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications